Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;23(3):538-544.
doi: 10.1111/jch.14116. Epub 2020 Dec 3.

Dietary intervention for the management of hypertension in Asia

Hao-Chih Chang  1 , Hao-Min Cheng  1   2   3   4 , Chen-Huan Chen  1   2   3   4 , Tzung-Dau Wang  5 , Arieska Ann Soenarta  6 , Yuda Turana  7 , Boon Wee Teo  8 , Jam Chin Tay  9 , Kelvin Tsoi  10 , Ji-Guang Wang  11 , Kazuomi Kario  12
Affiliations
Review

Dietary intervention for the management of hypertension in Asia

Hao-Chih Chang et al. J Clin Hypertens (Greenwich). 2021 Mar.

Abstract

Hypertension is among the leading global risks for premature death. As the risks substantially increase along with the elevated blood pressure, a small reduction of blood pressure could have prevented numerous cardiovascular events in general population. Evidence has shown that dietary intervention is a cost-effective strategy that has been broadly advocated in the published guidelines. However, the implementation could be limited by different food cultures. This review details the mechanisms of each dietary intervention approach, evidence, and the implications in Asian populations, and the perspective of future research.

Keywords: dietary intervention; hypertension.

PubMed Disclaimer

Conflict of interest statement

HM Cheng received speakers honorarium and sponsorship to attend conferences and CME seminars from Eli Lilly and AstraZeneca; Pfizer Inc; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc; Daiichi Sankyo, Novartis Pharmaceuticals, Inc; SERVIER; Co., Pharmaceuticals Corporation; Sanofi; TAKEDA Pharmaceuticals International and served as an advisor or consultant for ApoDx Technology, Inc CH Chen reports personal fees from Novartis, Sanofi, Daiichi Sankyo, SERVIER, and Boehringer Ingelheim Pharmaceuticals, Inc JG Wang reports having received research grants from Chendu Di‐Ao and Omron, and lecture and consulting fees from Astra‐Zeneca, Novartis, Omron, Servier, and Takeda. K Kario reports research grants from Omron Healthcare, Fukuda Denshi, A&D, Pfizer Japan, and honoraria from Omron Healthcare. All other authors report no potential conflicts of interest in relation to this article.

References

    1. GBDRF Collaborators . Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345‐1422. - PMC - PubMed
    1. Flint AC, Conell C, Ren X, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med. 2019;381:243‐251. - PubMed
    1. Lewington S, Clarke R, Qizilbash N, et al. Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903‐1913. - PubMed
    1. Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155:701‐709. - PubMed
    1. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117‐1124. - PubMed